Skip to main content
Livermore
Livermore
ZHEN

Cito Capital Group, LLC

SEC CIK
0001722439
Latest filing
Aug 14, 2026

ABT holding history

Abbott Laboratories in every 13F filed by Cito Capital Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2026 holdings

Shares (Q2 2026)
19,800
Value
$1.80M
% of portfolio
0.5%
Quarters held
22
Since Q1 2021
Holdings of ABT by Cito Capital Group, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202619,800$1.80M0.5%+2,100+11.9%AddedHolders
Q1 202617,700$1.82M0.6%+1,500+9.3%AddedHolders
Q4 202516,200$2.03M0.6%00.0%UnchangedHolders
Q3 202516,200$2.17M0.6%00.0%UnchangedHolders
Q2 202516,200$2.20M0.8%00.0%UnchangedHolders
Q1 202516,200$2.15M0.8%00.0%UnchangedHolders
Q4 202416,200$1.83M0.7%00.0%UnchangedHolders
Q3 202416,200$1.85M0.7%−2,750−14.5%ReducedHolders
Q2 202418,950$1.97M0.8%+850+4.7%AddedHolders
Q1 202418,100$2.06M0.8%00.0%UnchangedHolders
Q4 202318,100$1.99M0.9%+200+1.1%AddedHolders
Q3 202317,900$1.73M0.8%+400+2.3%AddedHolders
Q2 202317,500$1.91M0.9%00.0%UnchangedHolders
Q1 202317,500$1.77M0.9%00.0%UnchangedHolders
Q4 202217,500$1.92M1.1%00.0%UnchangedHolders
Q3 202217,500$1.69M1.0%−2,000−10.3%ReducedHolders
Q2 202219,500$2.12M1.2%00.0%UnchangedHolders
Q1 202219,500$2.31M1.1%−2,000−9.3%ReducedHolders
Q4 202121,500$3.03M1.3%00.0%UnchangedHolders
Q3 202121,500$2.54M1.2%−6,000−21.8%ReducedHolders
Q2 202127,500$3.19M1.4%00.0%UnchangedHolders
Q1 202127,500$3.30M1.6%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.